About Us
Our story
Born from frustration and optimism
Neuroprism was born out of the frustration of having neurodivergent children. This meant seeing our own children having to grow up with struggles, later diagnosed as autism, and experiencing a health care system that despites its best efforts, often could not provide timely assistance. It also comes from seeing the frustration of having close ones dealing with depression, and seeing the side effects of their medications, such as weight gain and lack of lust.
Neuroprism was started with optimism and a conviction of how new technology can offer new solutions, in the hands of dedicated entrepreneurs.
The three founders saw their drive to create new solutions for mental health diagnosis and therapy, combined with their unique experiences provided a formidable opportunity to do something truly valuable.
The Neuroprism founding team
Thomas Kallstenius
CEO
Thomas Kallstenius is the former CEO for the Luxembourg Institute of Science and Technology (LIST), the mission-driven Luxembourgish Research and Technology Organization that develops technology-intensive solutions focussed on environmental innovation, digitisation and advanced materials. Prior to this, he was program director for imec’s research & innovation program related to security and privacy. Thomas has also been vice president for research and innovation at iMinds, the research institute that merged with imec in 2016. His responsibilities in this role included iMinds’ strategic and applied research programs with academic and industrial partners.
Thomas holds a Masters Degree in Engineering Physics from the Royal Institute of Technology (Stockholm, Sweden), a PhD in semiconductor materials science from Uppsala University (Uppsala, Sweden) and an MBA from Vlerick Management School (Leuven, Belgium). He has served as a Member of the Board of Directors of the FTTH Council Europe, and as vice-chair of the Working Group on Wearables in the European Commission’s Alliance of Internet of Things Innovation (AIOTI).
Adam Williamson
Chief Research Officer
Adam Williamson is a Associate Professor of Neurophysiology at Linköping University, Sweden, and a Research Team Leader at St. Anne’s University Hospital in Brno, Czech Republic.
He received a bachelors and masters in Electrical Engineering from Texas Tech University, USA, and obtained his Ph.D. at the Technische Universität Ilmenau, Germany. Previously, he served as research scientist at the Institute of Neuroscience (INS), a part of Inserm at Aix-Marseille University (AMU) in France. He is a recipient of a record 5 European Research Council (ERC) grants.
His research focuses on in vivo applications of new electronic devices and methods of brain stimulation in epilepsy. His most recent ERC Consolidator grant specifically focuses on non-invasive deep brain modulation using Temporal Interference, a new non-invasive deep brain modulation method, to control epileptic brain activity in drug-resistant epilepsy patients.
Michael Daun
Chairman
Michael Daun is a Swedish serial entrepreneurial, innovator, speaker and inspirational leader with over 30 years industry expertise from internet/IT, strategy, leadership and consulting. Michael’s passion is to lead or advice organizations and leadership teams through times of growth or change, and disrupting current business practice.
Michael was an early internet pioneer leaving his Ph.D. career at Stockholms School of Economics to introduce world wide web within the media group Kinnevik. He then turned entrepreneur, starting Spray – Swedens pioneering internet group. He then co-founded the management consultancy Fluidminds which served as advisors on the new economy for large entreprises seeking innovation and speed in strategy and leadership. Michael co-founded Scandinavia’s first co-working space United Spaces. Michael then founded Cultr.works – a platfrom for activating desired behaviours and mindsets in organisation. Michael has been an angel investor in many start-ups, frequently taking on positions on boards or advisory roles. Michael holds a M.Sc in International Business from the Stockholm School of Economics.
Neuroprism Advisors
Dr. Michael Treadway
Medical Expert
Dr. Treadway is a cognitive neuroscientist and licensed clinical psychologist. He received his PhD in clinical psychology from Vanderbilt University in 2012, and completed his clinical internship and post-doc at McLean Hospital/Harvard Medical School.
Dr. Negar Fani
Medical Expert
Dr. Negar Fani is a clinical neuropsychologist and tenured Associate Professor, Associate Vice Chair of Translational Research and Director of the Temporal Interference Neuromodulation Program in the Department of Psychiatry and Behavioral Sciences. She is also an affiliate faculty member for the Neuroscience and Molecular and Systems Pharmacology Graduate Programs.
Prof. Markus Heilig
Research and Trials advisor
Professor Markus Heilig is the Founding Director of the interdisciplinary Center for Social and Affective Neuroscience of Linköping University and the region of Östergötland, a major initiative supported by the Swedish Research Council.
Prof. Heilig is an elected member of the Royal Swedish Academy of Sciences, a Wallenberg Foundation Clinical Fellow, a Fellow of the American College of Neuropsychopharmacology, an editor at Neuropsychopharmacology, and a scientific advisor to the Swedish Medical Products Agency. Heilig has received numerous, prestigious awards and has authored more than 200 peer reviewed journal articles in high impact journals such as Science, PNAS, Lancet, Archives of General Psychiatry.
Join our team!
Feeling inspired? Join the team
Do you dream of making a big impact? Do you wish to apply your capabilities within an organization of risk-takers, critical thinkers and doers? Do you feel different? Do you want to bring magic to the world? Send us a mail with your CV and a very short text about what you could contribute to our mission and team.